HR7336-119

In Committee

ALS Better Care Act

119th Congress Introduced Feb 3, 2026

Summary

What This Bill Does

This bill treats ALS care as a Medicare-covered service package rather than a set of separately underpaid supports. It defines ALS-related services to include specialized physician or nurse-practitioner support, occupational therapy, speech pathology, physical therapy, dietary and respiratory support, registered nurse support, and durable-medical-equipment coordination for covered ALS individuals. Beginning January 1, 2027, Medicare would pay ALS care providers a supplemental single payment, initially $800, with market-basket updates, GAO-recommended resets every third year, clinical-trial participation adjustments, new-service or technology adjustments, ICD-10-CM claim mechanics, and no beneficiary cost sharing.

Who Benefits and How

ALS patients, Medicare beneficiaries with ALS, ALS care providers, telehealth providers, and ALS clinical trial researchers benefit from covered multidisciplinary outpatient care and a dedicated Medicare reimbursement stream. The payment adjustment for clinical-trial participation gives ALS research centers a clearer way to absorb trial-related care costs.

Who Bears the Burden and How

CMS, the Department of Health and Human Services, the HHS Office of the Secretary, Medicare claims administrators, the Comptroller General, the National Institutes of Health, and NINDS staff must implement the coverage category, payment mechanism, claims code requirements, provider qualifications, GAO payment recommendations, and clinical-trial staffing report.

Key Provisions

  • Adds ALS-related outpatient services to Medicare coverage for covered ALS individuals beginning January 1, 2027.
  • Creates a supplemental single-payment system starting at $800 in 2027, with inflation updates, GAO-recommended resets, clinical-trial adjustments, and no beneficiary cost sharing.
  • Requires qualified-provider standards to be developed through rulemaking after consultation with ALS patients, physicians, and nonprofit experts.
  • Directs NINDS to report to Congress on ALS clinical-trial staffing, administration challenges, corrective actions, and legislative recommendations.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Adds Medicare coverage and a dedicated payment system for ALS-related outpatient services, including a $800 base payment in 2027 and required GAO reviews of payment adequacy.

Key Policy Areas

Healthcare, Medicare, Research

Primary Purpose

Adds Medicare coverage and a dedicated payment system for ALS-related outpatient services, including a $800 base payment in 2027 and required GAO reviews of payment adequacy.

Policy Domains

Healthcare Medicare Research

Substantive provisions

Identified Gains
  • ALS patients
  • Medicare beneficiaries with ALS
  • ALS care providers
  • Telehealth providers
  • ALS clinical trial researchers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
ALS patients: ,
ALS care providers: ,
Telehealth providers: ,
ALS clinical trial researchers: ,
Medicare beneficiaries with ALS: ,
Identified Costs
  • CMS
  • Department of Health and Human Services
  • HHS Office of the Secretary
  • Medicare claims administrators
  • Comptroller General
  • National Institutes of Health
  • NINDS staff
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
CMS: ,
NINDS staff: ,
Comptroller General: ,
HHS Office of the Secretary: ,
National Institutes of Health: ,
Medicare claims administrators: ,
Department of Health and Human Services: ,

Legislative Progress

In Committee
Introduced Committee Passed
Feb 3, 2026

Referred to the Committee on Energy and Commerce, and in …

Feb 3, 2026

Introduced in House

Feb 3, 2026

Ms. Schakowsky (for herself, Mr. Fitzpatrick, Mr. Crow, and Mr. …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare Beneficiaries
3 mentions across 2 clauses
+2 positive -1 negative

CMS, Medicare beneficiaries with ALS

Positive-direction: Medicare beneficiaries with ALS

Negative-direction: CMS

Healthcare
3 mentions across 2 clauses
+3 positive

ALS clinics, Qualified ALS providers

Research & Science
3 mentions across 1 clause
+2 positive -1 negative

ALS clinical trial sites, ALS researchers, NINDS

Positive-direction: ALS clinical trial sites, ALS researchers

Negative-direction: NINDS

Government
1 mention across 1 clause
-1 negative

Comptroller General

3/4
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Medicare Research
Actor Mappings
"Director"
→ Director of the National Institute of Neurological Disorders and Stroke
"Secretary"
→ Secretary of Health and Human Services
"Comptroller General"
→ Comptroller General of the United States

Key Definitions

Terms defined in this bill

1 term
"ALS-related services" §3

A multidisciplinary outpatient package for covered ALS individuals including physician, therapy, dietary, respiratory, nursing, and durable-medical-equipment coordination services.

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology